This breakfast is catered to postgrads (Masters/PhD) and postdocs of any stage and will be hosted by Jake Baum and Freddy Frischknecht. The event will include discussion opportunities with mentors from a diversity of career paths, held over a delicious breakfast.
Professor Frischknecht studied biochemistry at the Free University of Berlin and did his PhD at the European Molecular Biology Laboratory in Heidelberg working on how poxviruses use the actin cytoskeleton to spread from cell to cell. For his postdoc he joined the Institut Pasteur in Paris with an EMBO and an HFSP fellowship working on in vivo imaging of the migration of Plasmodium sporozoites during transmission of malaria. In 2005 he started his lab at the University of Heidelberg with a focus on understanding the mechanisms of sporozoite migration. The lab uses reverse genetics, advanced imaging and biophysics methods and also aims to generate genetically attenuated parasites for experimental vaccination. In 2014 he became full professor and in 2022 EMBO member.
Professor Jake Baum studied biological sciences and biological anthropology at Oxford University prior to doing a PhD at the London School of Hygiene and Tropical Medicine, working on coevolutionary population genetics between malaria parasites and humans. He moved to Melbourne in 2003 to complete a postdoc with Alan Cowman at the WEHI to work on the cell biology of blood stage malaria (invasion), before starting his own lab in 2010. After diversifying into parasite lifecycle cell biology, in 2013 he moved back to the UK to set up a new lab at Imperial College London, developing programs on malaria diagnostics, drug discovery and vaccinology. He was appointed full Professor in 2017 and inaugural Director of the Imperial College Institute of Infection in 2020. Most recently (2022), hopefully for the last time!, he moved back to Australia, this time to UNSW Sydney, where he took up the role as Head of School, Biomedical Sciences whilst also running a new lab exclusively focussed on malaria parasite transmission biology and next generation vaccinology. Eclectic in focus, the Baum lab (www.baumlab.com) has enjoyed several productive industry partnerships (GSK, Novartis and Google) and received generous research funding (often with international collaborators) from several funding agencies including the Gates Foundation, NIH, HFSPO, Wellcome, UK MRC and the Australian NHMRC.